Trillium Therapeutics Inc. (TRIL) Tumbled -7.66% or -0.18 To Price $2.18 On Thursday

Trillium Therapeutics Inc. (TRIL) tumbled -7.66% or -0.18 to $2.18. It is near 37453 shares traded, which is 42.44% compare to the average total volume 88252. The market cap of TRIL is $32.07 million. The year to date change is -77.83%. The 52 week price range is from $2.01 to $11.5. Price of TRIL have changed -15.26% during last week. It have changed -26.58% over last month, -60.43% over last 3 months, -62.77% over last 6 months and -77.27% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for TRIL is 3.70. It is 69.72% above current price. The 200-day Moving Averages for TRIL is 5.62. It is 157.80% above current price. The 52-week High is 11.5. It is 427.52% from the current price. The 52-week Low is 2.01. It is -7.80% from current price.

There are some statistics of TRIL. It is has market cap $32.07 million. The share outstanding is 14.69 million. The average volume is 88252. The percent of top 15 Institution holding is 55.80%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of TRIL is -627.91%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of TRIL is -62.50%.


Share this post